Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides.
葉酸修飾的逆微胞脂質奈米膠囊克服腸道障礙並改善肽的口服給藥。
Drug Deliv 2023-03-04
Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery.
設計利用寡聚膽酸的嵌合GLP-1A,以利用轉運蛋白介導的內吞作用進行口服給藥。
Biomater Res 2023-11-21
Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide.
靶向腸道 Fc 受體的奈米粒子增強 semaglutide 在腸道細胞中的運輸。
J Control Release 2024-03-04
Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience.
鈉N-(8-[2-羥基苯甲酰]氨基)癸酸酯(SNAC)作為吸收增強劑的目前認識:口服Semaglutide的經驗。
Clin Diabetes 2024-01-18
Coordinated ASBT and EGFR Mechanisms for Optimized Liraglutide Nanoformulation Absorption in the GI Tract.
ASBT和EGFR協調機制對於在胃腸道中優化Liraglutide納米配方吸收的作用。
Int J Nanomedicine 2024-03-29
Enhancing the Therapeutic Efficacy of GLP-1 for Hyperglycemia Treatment: Overcoming Barriers of Oral Gene Therapy with Taurocholic Acid-Conjugated Protamine Sulfate and Calcium Phosphate.
提升 GLP-1 治療高血糖的療效:克服口服基因治療障礙的方法 - 利用牛磺胺膽酸共軛的胰蛋白酶硫酸鹽和磷酸鈣。
ACS Nanosci Au 2024-06-24
Enhanced Oral Efficacy of Semaglutide via an Ionic Nanocomplex with Organometallic Phyllosilicate in Type 2 Diabetic Rats.
透過有機金屬層狀矽酸鹽的離子納米複合物增強 Semaglutide 在 2 型糖尿病大鼠中的口服療效。
Pharmaceutics 2024-07-27
The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide.
SNAC 酚酸鹽的合成及其對 Semaglutide 口服生物利用度的影響。
Molecules 2024-08-29